Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Alzheimer's disease & dementia

Could a computer diagnose Alzheimer's disease and dementia?

It takes a lot of time—and money—to diagnose Alzheimer's disease. After running lengthy in-person neuropsychological exams, clinicians have to transcribe, review, and analyze every response in detail. But researchers ...

Neuroscience

A neurobiological model to better understand creative processes

"Many believe that creativity is assigned to a single brain region. But that is not the case," says Radwa Khalil. Together with scientists from South Africa and Australia, the neurobiologist at Jacobs University Bremen has ...

page 3 from 17